Valeant completes iNova acquisition

MISSISSAUGA, Ontario — Canadian drug maker Valeant Pharmaceuticals officially owns an Australian drug maker.

The company announced that it completed its acquisition of iNova, which sells and distributes prescription and over-the-counter drugs in Australia, New Zealand, Southeast Asia and South Africa, on Dec. 21 from iNova's current shareholders, Archer Capital, Ironbridge and others.

The deal, which was announced back in November, was valued at up to A$700 million.

Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.